Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Apr 10 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

The approval allows Zydus to manufacture and market the drug, which treats various bacterial infections. The tablets will be produced at the company's facility in Moraiya, Ahmedabad.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases